A review of 11 studies suggests endometriosis may take a cumulative toll on work, but long-term data are scarce.

With the approval, there's a rival to perioperative pembrolizumab with enfortumab vedotin for patients with cisplatin-ineligible muscle-invasive bladder cancer.

Dapagliflozin may improve ascites control in patients with cirrhosis and refractory ascites and reduce the need for ...

Bulevirtide use in patients with hepatitis D-related cirrhosis is linked with less liver decompensation over 3 years, but its ...